Jamie R. Doyle

457 total citations
12 papers, 243 citations indexed

About

Jamie R. Doyle is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jamie R. Doyle has authored 12 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jamie R. Doyle's work include Cystic Fibrosis Research Advances (3 papers), Neuropeptides and Animal Physiology (3 papers) and Receptor Mechanisms and Signaling (2 papers). Jamie R. Doyle is often cited by papers focused on Cystic Fibrosis Research Advances (3 papers), Neuropeptides and Animal Physiology (3 papers) and Receptor Mechanisms and Signaling (2 papers). Jamie R. Doyle collaborates with scholars based in United States, Netherlands and Israel. Jamie R. Doyle's co-authors include Alan S. Kopin, Bryan K. Yamamoto, Jacqueline M. Lane, Amiel G. Cooper, N Grace, Rie Ookubo, Jean‐Philippe Fortin, Benjamin N. Smith, Mortimer S. Greenberg and Brinda R. Kamat and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Jamie R. Doyle

12 papers receiving 239 citations

Peers

Jamie R. Doyle
John E. Cuffe United Kingdom
Julia A. Fox United States
Brooke Ligon United States
Changyong Hu Singapore
Jacob M. Winter United States
Arthur Kmit Portugal
John E. Cuffe United Kingdom
Jamie R. Doyle
Citations per year, relative to Jamie R. Doyle Jamie R. Doyle (= 1×) peers John E. Cuffe

Countries citing papers authored by Jamie R. Doyle

Since Specialization
Citations

This map shows the geographic impact of Jamie R. Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamie R. Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamie R. Doyle more than expected).

Fields of papers citing papers by Jamie R. Doyle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamie R. Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamie R. Doyle. The network helps show where Jamie R. Doyle may publish in the future.

Co-authorship network of co-authors of Jamie R. Doyle

This figure shows the co-authorship network connecting the top 25 collaborators of Jamie R. Doyle. A scholar is included among the top collaborators of Jamie R. Doyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamie R. Doyle. Jamie R. Doyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Montanari, Vittorio, Jamie R. Doyle, Maribel Rios, et al.. (2021). A Non-Perturbative Molecular Grafting Strategy for Stable and Potent Therapeutic Peptide Ligands. ACS Central Science. 7(3). 454–466. 10 indexed citations
2.
Kerem, Eitan, Malena Cohen‐Cymberknoh, Michael Wilschanski, et al.. (2020). Ivacaftor in People with Cystic Fibrosis and a 3849+10kb CT or D1152H Residual Function Mutation. Annals of the American Thoracic Society. 18(3). 433–441. 22 indexed citations
3.
Doyle, Jamie R., et al.. (2020). OFF bipolar cell density varies by subtype, eccentricity, and along the dorsal ventral axis in the mouse retina. The Journal of Comparative Neurology. 529(8). 1911–1925. 9 indexed citations
4.
Berkers, Gitte, Renske van der Meer, Harry Heijerman, et al.. (2020). Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E–CFTR mutation. Journal of Cystic Fibrosis. 20(5). 761–767. 12 indexed citations
5.
Kelly, Siobhán, et al.. (2015). Ivacaftor as salvage therapy in a patient with cystic fibrosis genotype F508del/R117H/IVS8-5T. Journal of Cystic Fibrosis. 14(4). e4–e5. 13 indexed citations
6.
Lane, Jacqueline M., Jamie R. Doyle, Jean‐Philippe Fortin, Alan S. Kopin, & José M. Ordovás. (2014). Development of an OP9 Derived Cell Line as a Robust Model to Rapidly Study Adipocyte Differentiation. PLoS ONE. 9(11). e112123–e112123. 26 indexed citations
7.
Doyle, Jamie R., Zhen‐Zhong Xu, Daniel Heller-Trulli, et al.. (2014). Development of a Membrane-anchored Chemerin Receptor Agonist as a Novel Modulator of Allergic Airway Inflammation and Neuropathic Pain. Journal of Biological Chemistry. 289(19). 13385–13396. 24 indexed citations
8.
Doyle, Jamie R., Vijay M. Krishnamurthy, Wei-En Lin, et al.. (2014). A Two-Step Strategy to Enhance Activity of Low Potency Peptides. PLoS ONE. 9(11). e110502–e110502. 5 indexed citations
10.
Doyle, Jamie R., Jacqueline M. Lane, Martin Beinborn, & Alan S. Kopin. (2012). Naturally occurring HCA1 missense mutations result in loss of function: potential impact on lipid deposition. Journal of Lipid Research. 54(3). 823–830. 6 indexed citations
11.
Doyle, Jamie R. & Bryan K. Yamamoto. (2009). Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine. Psychoneuroendocrinology. 35(4). 629–633. 19 indexed citations
12.
Smith, Benjamin N., N Grace, Mortimer S. Greenberg, et al.. (1997). Prevalence of hereditary hemochromatosis in a Massachusetts corporation: Is Celtic origin a risk factor?. Hepatology. 25(6). 1439–1446. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026